Eyal Sagiv

865 total citations
28 papers, 644 citations indexed

About

Eyal Sagiv is a scholar working on Oncology, Surgery and Pharmacology. According to data from OpenAlex, Eyal Sagiv has authored 28 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Eyal Sagiv's work include Inflammatory mediators and NSAID effects (5 papers), Kawasaki Disease and Coronary Complications (4 papers) and Genetic factors in colorectal cancer (4 papers). Eyal Sagiv is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Kawasaki Disease and Coronary Complications (4 papers) and Genetic factors in colorectal cancer (4 papers). Eyal Sagiv collaborates with scholars based in United States, Israel and United Kingdom. Eyal Sagiv's co-authors include Nadir Arber, Diana Kazanov, Uri Rozovski, Alex Starr, Peter Altevogt, Timothy C. Wang, Rami Khosravi, Eliezer Liberman, Dina Kazanov and Michael A. Portman and has published in prestigious journals such as Gastroenterology, Cancer and Cancer Research.

In The Last Decade

Eyal Sagiv

28 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyal Sagiv United States 11 249 237 99 93 68 28 644
Pun Hui Hong Kong 9 286 1.1× 175 0.7× 116 1.2× 60 0.6× 82 1.2× 13 1.4k
Guido Bisping Germany 17 302 1.2× 436 1.8× 44 0.4× 106 1.1× 53 0.8× 28 845
Marí­a José Herrero Spain 19 310 1.2× 442 1.9× 146 1.5× 251 2.7× 101 1.5× 90 1.2k
Hiroshi Tsutani Japan 16 160 0.6× 338 1.4× 101 1.0× 176 1.9× 54 0.8× 82 979
Suman Kundu United States 15 134 0.5× 201 0.8× 30 0.3× 162 1.7× 60 0.9× 37 622
Hiroaki Ohnishi Japan 16 274 1.1× 291 1.2× 49 0.5× 73 0.8× 31 0.5× 52 774
Susanne A. Gatz United Kingdom 16 267 1.1× 416 1.8× 60 0.6× 150 1.6× 36 0.5× 35 887
CA Eekman Netherlands 8 465 1.9× 384 1.6× 58 0.6× 41 0.4× 66 1.0× 8 725
Iris M. De Cuyper Netherlands 16 100 0.4× 148 0.6× 98 1.0× 143 1.5× 59 0.9× 26 692
Amu Therwath France 16 210 0.8× 257 1.1× 36 0.4× 167 1.8× 62 0.9× 39 745

Countries citing papers authored by Eyal Sagiv

Since Specialization
Citations

This map shows the geographic impact of Eyal Sagiv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Sagiv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Sagiv more than expected).

Fields of papers citing papers by Eyal Sagiv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Sagiv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Sagiv. The network helps show where Eyal Sagiv may publish in the future.

Co-authorship network of co-authors of Eyal Sagiv

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Sagiv. A scholar is included among the top collaborators of Eyal Sagiv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Sagiv. Eyal Sagiv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Marshall, et al.. (2024). Monitoring abdominal near-infrared spectroscopy during feeds in neonates with CHD recovering from surgery: a feasibility study. Cardiology in the Young. 34(11). 2355–2361. 1 indexed citations
2.
Sagiv, Eyal, et al.. (2023). Real-world experience with edoxaban for anticoagulation in children at risk for coronary artery thrombosis. Cardiology in the Young. 34(4). 870–875. 2 indexed citations
3.
Sagiv, Eyal, et al.. (2022). Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial. Cardiology in the Young. 33(4). 613–618. 4 indexed citations
4.
Sagiv, Eyal, et al.. (2022). Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn. Annals of Pediatric Cardiology. 15(1). 58–60. 8 indexed citations
5.
Taggart, Nathaniel W., Eyal Sagiv, Utkarsh Kohli, et al.. (2022). Applying Practice Analysis to Develop a New Test Content Outline for the Pediatric Cardiology Certification Examination. Pediatric Cardiology. 44(5). 1057–1067. 4 indexed citations
6.
Buddhe, Sujatha, et al.. (2021). Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. The Journal of Pediatrics. 238. 317–320. 44 indexed citations
7.
Ganigara, Madhusudan, Eyal Sagiv, Sujatha Buddhe, Aarti Bhat, & Sathish Chikkabyrappa. (2020). Tetralogy of Fallot With Pulmonary Atresia: Anatomy, Physiology, Imaging, and Perioperative Management. Seminars in Cardiothoracic and Vascular Anesthesia. 25(3). 208–217. 7 indexed citations
8.
Sagiv, Eyal, Ross M. Fasano, Naomi L.C. Luban, et al.. (2018). Glucose‐6‐phosphate‐dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease. American Journal of Hematology. 93(5). 630–634. 31 indexed citations
10.
Sagiv, Eyal, Michal Sheffer, Diana Kazanov, et al.. (2009). S1971 Celecoxib Selectively Targets Genes and Pathways Involved in Inflammation and Malignant Transformation in Tumor But Not Normal Cells. Gastroenterology. 136(5). A–304. 1 indexed citations
11.
Hall, Michael J., Eliezer Liberman, Eyal Sagiv, et al.. (2009). Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Annals of Oncology. 20(9). 1517–1521. 8 indexed citations
12.
Sagiv, Eyal, Alex Starr, Uri Rozovski, et al.. (2008). Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA. Cancer Research. 68(8). 2803–2812. 134 indexed citations
13.
Liberman, Eliezer, Diana Kazanov, Hadas Dvory‐Sobol, et al.. (2008). Malignant Transformation of Normal Enterocytes following Downregulation of Bak Expression. Digestion. 77(1). 48–56. 5 indexed citations
14.
Sagiv, Eyal & Nadir Arber. (2008). The novel oncogeneCD24and its arising role in the carcinogenesis of the GI tract: from research to therapy. Expert Review of Gastroenterology & Hepatology. 2(1). 125–133. 47 indexed citations
15.
Dvory‐Sobol, Hadas, et al.. (2007). Gene therapy approach in prostate cancer cells using an active Wnt signal. Biomedicine & Pharmacotherapy. 61(9). 527–530. 5 indexed citations
16.
Liberman, Eliezer, et al.. (2007). The APC E1317Q and I1307K polymorphisms in non-colorectal cancers. Biomedicine & Pharmacotherapy. 61(9). 566–569. 10 indexed citations
17.
Sagiv, Eyal, Uri Rozovski, Diana Kazanov, Eliezer Liberman, & Nadir Arber. (2007). Gene Expression Analysis Proposes Alternative Pathways for the Mechanism by Which Celecoxib Selectively Inhibits the Growth of Transformed but not Normal Enterocytes. Clinical Cancer Research. 13(22). 6807–6815. 7 indexed citations
18.
Sagiv, Eyal, Dina Kazanov, & Nadir Arber. (2006). CD24 plays an important role in the carcinogenesis process of the pancreas. Biomedicine & Pharmacotherapy. 60(6). 280–284. 40 indexed citations
19.
Dvory‐Sobol, Hadas, Eyal Sagiv, Eliezer Liberman, Diana Kazanov, & Nadir Arber. (2006). Suppression of gastric cancer cell growth by targeting the β‐catenin/T‐cell factor pathway. Cancer. 109(2). 188–197. 25 indexed citations
20.
Sagiv, Eyal, Lorenzo Memeo, Diana Kazanov, et al.. (2006). CD24 Is a New Oncogene, Early at the Multistep Process of Colorectal Cancer Carcinogenesis. Gastroenterology. 131(2). 630–639. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026